Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Leukemia

Free Subscription 24.06.2024 1 Am J Hematol 4 Ann Hematol 1 Biochem Biophys Res Commun 1 Biochem Pharmacol 5 Blood 1 BMC Cancer 1 Bone Marrow Transplant 1 Cancer 1 Cancer Chemother Pharmacol 1 Cancer Lett 1 Cancer Res 1 Exp Hematol 2 J Clin Oncol 4 Leukemia 1 Oncogene 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Hematol

1. GARCIAZ S, Dumas PY, Bertoli S, Sallman DA, et al
   Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment.
   Am J Hematol. 2024 Jun 20. doi: 10.1002/ajh.27417.
   PubMed         Abstract available
   
   

   
   Ann Hematol

2. CAO X, Li Z, Zhang Y, Cui Q, et al
   Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation.
   Ann Hematol. 2024 Jun 20. doi: 10.1007/s00277-024-05849.
   PubMed         Abstract available
   
   
3. ZHOU K, Wang T, Pan L, Xu W, et al
   Improved efficacy and safety of zanubrutinib versus ibrutinib in patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL) in China: a subgroup of ALPINE.
   Ann Hematol. 2024 Jun 18. doi: 10.1007/s00277-024-05823.
   PubMed         Abstract available
   
   
4. WANG XZ, Gao XM, Wang JM, Cai H, et al
   Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations.
   Ann Hematol. 2024 Jun 15. doi: 10.1007/s00277-024-05842.
   PubMed         Abstract available
   
   
5. ABULIMITI M, Jia ZY, Wu Y, Yu J, et al
   Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia.
   Ann Hematol. 2024 Jun 15. doi: 10.1007/s00277-024-05841.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

6. NAM H, Kim D, Jin X, Park S, et al
   Metabolic determinants of leukemia onset variability in genetically homogeneous AKR mice.
   Biochem Biophys Res Commun. 2024;725:150257.
   PubMed         Abstract available
   
   

   
   Biochem Pharmacol

7. CHIOU JT, Lee YC, Huang CH, Wang LJ, et al
   Corrigendum to "Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells" [Biochem. Pharmacol.188 (2021) 114544].
   Biochem Pharmacol. 2024;226:116359.
   PubMed        
   
   

   
   Blood

8. BARTRAM J, Ancliff P, Vora A
   How I Treat on Infant Acute Lymphoblastic Leukemia.
   Blood. 2024 Jun 21:blood.2023023154. doi: 10.1182/blood.2023023154.
   PubMed         Abstract available
   
   
9. 
   Garcia E, Horowitz AM, Franklin K, Mader M, Kaur S. Outcomes of veterans with FMS-like tyrosine kinase 3 mutated (mFLT3) acute myeloid leukemia (AML) treated with novel FLT3 inhibitors (FLT3i) within the Veterans Health Administration (VHA) [abstract]
   Blood. 2024;143:2676.
   PubMed        
   
   
10. FORCONI F
    Time for a new prognostic score in CLL?
    Blood. 2024;143:2561-2562.
    PubMed        
    
    
11. GAO Q, Harrison CJ
    B-ALL with intrachromosomal amplification of chromosome 21 in a carrier of the Robertsonian translocation rob(14;21)c.
    Blood. 2024;143:2672.
    PubMed        
    
    
12. SATO T, Yoshida K, Toki T, Kanezaki R, et al
    Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.
    Blood. 2024;143:2627-2643.
    PubMed         Abstract available
    
    

    
    BMC Cancer

13. KUAN JW, Su AT, Sim SP, Tay SP, et al
    Higher prevalence of harbouring BCR::ABL1 in first-degree relatives of chronic myeloid leukaemia (CML) patients compared to normal population.
    BMC Cancer. 2024;24:734.
    PubMed         Abstract available
    
    

    
    Bone Marrow Transplant

14. ZHU J, Xu M, Ye Y, Ru Y, et al
    Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study.
    Bone Marrow Transplant. 2024 Jun 19. doi: 10.1038/s41409-024-02335.
    PubMed        
    
    

    
    Cancer

15. LABRADOR J, Martinez-Cuadron D, Boluda B, Serrano J, et al
    Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
    Cancer. 2024 Jun 19. doi: 10.1002/cncr.35431.
    PubMed         Abstract available
    
    

    
    Cancer Chemother Pharmacol

16. CEREJA-PANTOJA KBC, de Brito Azevedo TC, Vinagre LWMS, de Moraes FCA, et al
    Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population.
    Cancer Chemother Pharmacol. 2024 Jun 18. doi: 10.1007/s00280-024-04689.
    PubMed         Abstract available
    
    

    
    Cancer Lett

17. WANG J, Ma W, Huang J, Qiu G, et al
    HIF-2alpha Inhibition Disrupts Leukemia Stem Cell Metabolism and Impairs Vascular Microenvironment to Enhance Chronic Myeloid Leukemia Treatment.
    Cancer Lett. 2024 Jun 14:217060. doi: 10.1016/j.canlet.2024.217060.
    PubMed         Abstract available
    
    

    
    Cancer Res

18. POORT VM, Hagelaar R, van Roosmalen MJ, Trabut L, et al
    Transient Differentiation-State Plasticity Occurs During Acute Lymphoblastic Leukemia Initiation.
    Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-24-1090.
    PubMed         Abstract available
    
    

    
    Exp Hematol

19. ONG KOK, Mok MMH, Niibori-Nambu A, Du L, et al
    Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia.
    Exp Hematol. 2024 Jun 12:104255. doi: 10.1016/j.exphem.2024.104255.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

20. TIERENS A, Arad-Cohen N, Cheuk D, De Moerloose B, et al
    Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.
    J Clin Oncol. 2024;42:2174-2185.
    PubMed         Abstract available
    
    
21. TIONG IS, Hiwase DK, Abro E, Bajel A, et al
    Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).
    J Clin Oncol. 2024;42:2161-2173.
    PubMed         Abstract available
    
    

    
    Leukemia

22. ABOU DALLE I, Moukalled N, El Cheikh J, Mohty M, et al
    Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions.
    Leukemia. 2024 Jun 20. doi: 10.1038/s41375-024-02319.
    PubMed         Abstract available
    
    
23. MCCARTHY N, Gui G, Dumezy F, Roumier C, et al
    Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance.
    Leukemia. 2024 Jun 18. doi: 10.1038/s41375-024-02300.
    PubMed         Abstract available
    
    
24. MIAO H, Chen D, Ropa J, Purohit T, et al
    Combination of menin and kinase inhibitors as an effective treatment for leukemia with NUP98 translocations.
    Leukemia. 2024 Jun 18. doi: 10.1038/s41375-024-02312.
    PubMed         Abstract available
    
    
25. SALA-TORRA O, Beppu L, Wu Q, Welch E, et al
    Point-of-care BCR::ABL1 transcript monitoring using capillary dried blood in chronic myeloid leukemia patients.
    Leukemia. 2024 Jun 15. doi: 10.1038/s41375-024-02285.
    PubMed        
    
    

    
    Oncogene

26. WANG G, Zhang W, Ren J, Zeng Y, et al
    The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
    Oncogene. 2024;43:1900-1916.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

27. SMOLKO AE, Sullivan DW, Olsen SN, Kang H, et al
    A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes.
    Proc Natl Acad Sci U S A. 2024;121:e2405905121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.